About Index Trending news
Lists
Pricing
Eleven Biotherapeutics

Eleven Biotherapeutics

Eleven Biotherapeutics

Eleven Biotherapeutics is focused on developing innovative protein-based therapeutics to improve human health and treat diseases.

Elsewhere

Alexa global traffic share

Latest funding
Post-IPO equity
$20,000,000
Venture capital (Series A)
$35,000,000
Employees

Team size

10+
Locations
HQ
Acquisition
Seeking Alpha , businesswire

Eleven Biotherapeutics acquires Viventia Bio in all-stock deal